We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3533:TWSELotes Co., Ltd Analysis

Data as of 2026-05-18 - not real-time

NT$2,325.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Lotes Co., Ltd. is currently riding a bullish price trend, with the market price sitting above key short‑term support levels while still below longer‑term averages, indicating upside potential if momentum sustains. Technical signals are mixed: the RSI sits in a neutral zone suggesting neither overbought nor oversold conditions, the MACD histogram is negative pointing to bearish momentum, yet volume is on an upward trajectory, reinforcing the bullish bias. Fundamental metrics show robust revenue growth and healthy operating margins, but valuation multiples are elevated relative to the industry, and the discounted cash flow model places the intrinsic value below the current market price. The dividend payout is moderate with a comfortable coverage ratio, supporting the view that the dividend remains sustainable.
Overall, the stock presents a nuanced picture: strong operational fundamentals and a supportive macro sentiment (as reflected by an extreme greed market tone) are offset by a potentially overvalued price and mixed short‑term technical cues.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Mixed technical signals with bearish MACD histogram
  • Neutral RSI indicating limited short‑term momentum
  • Current price above short‑term support but below longer‑term averages

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and solid operating margins
  • Increasing volume supporting price appreciation
  • Forward earnings multiple compressing relative to trailing multiple

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained dividend payout with healthy cash flow coverage
  • Strategic position in high‑growth electronic components market
  • Fundamental fundamentals outpacing industry peers despite current valuation

Key Metrics & Analysis

Financial Health

Revenue Growth20.10%
Profit Margin22.60%
P/E Ratio33.2
ROE19.07%
ROA12.52%
Debt/Equity2.12
P/B Ratio6.2
Op. Cash FlowNT$7.2B
Free Cash FlowNT$838.5M
Industry P/E38.2

Technical Analysis

TrendBullish
RSI43.8
SupportNT$2,225.00
ResistanceNT$2,955.00
MA 20NT$2,613.25
MA 50NT$2,260.20
MA 200NT$1,632.35
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair ValueNT$342.47
Target PriceNT$2,664.86
Upside/Downside14.62%
GradeOvervalued
TypeGrowth
Dividend Yield1.79%

Risk Assessment

Beta1.03
Volatility74.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.